胶束电动毛细管色谱法同时测定血清中苯巴比妥、苯妥英钠和卡马西平

建立了血清中苯巴比妥、苯妥英钠和卡马西平的胶束电动毛细管色谱(MEKC)分析法。方法以巴比妥钠为内标物,10 mmol/L磷酸氢二钠溶液-30 mmol/L十二烷基硫酸钠(胶束相)-15%甲醇为缓冲液(pH=8.50),恒定电压18 kV,检测波长210 nm。本法测定苯巴比妥和苯妥英钠两种药物的线性范围为2.5~80μg/mL(r≥0.9990),检出限为0.5μg/mL;测定卡马西平的线性范围为1~32μg/mL(r=0.9999),检出限为1.0μg/mL。方法快速、简便、结果准确,适合于临床应用。     

血、尿中氯硝西泮及其代谢物7-氨基氯硝西泮的GC-ECD法检测

报道了血、尿中氯硝西泮及其代谢物7－氨基氯硝西泮的GC－ECD检测方法。苯－异戊醇碱性条件下（pH10.8）液－液萃取，灵敏度较高，氯硝西泮和7－氨基氯硝西泮的检测限（LOD）分别为3．2ng/mL及1．7ng/mL。线性范围5－300ng/mL，RSD5．3％。     

高效液相色谱法测定血浆中的乙酰螺旋霉素

乙酰螺旋霉素(Ac-SPM)是近年来广泛应用于临床的一种十六碳大环内酯类抗生素,其体内外抗菌活性均优于螺旋霉素。Ac-SPM是双乙酰螺旋霉素Ⅱ、Ⅲ和单乙酰螺旋霉素Ⅱ、Ⅲ四个组分的混合物。我们采用柱色谱法,在薄层色谱法(TLC)的监测下,分离制得Ac-SPM的各组分标准品,以此为     

自动固相萃取/液相色谱-串联质谱法测定血液中氯硝西泮及其代谢产物7-氨基氯硝西泮

建立了血液中氯硝西泮及其代谢产物7-氨基氯硝西泮的自动固相萃取/液相色谱-串联质谱(ASPE/LC-MS/MS)分析方法。样品经C18固相萃取柱提取后,采用LC-MS/MS进行测定,外标法定量。在Waters Atlantis TM d C18反相柱上分离,梯度洗脱,流动相为甲醇和0.1%甲酸水溶液,质谱采集为电喷雾正离子多反应监测模式。2种目标物在2~1 000μg/L范围内具有良好的线性关系,相关系数为0.995 9~0.998 2,检出限为0.2~0.5μg/L;加标水平为50,200,1 000μg/L时,方法的回收率为72.6%~96.3%,相对标准偏差为4.2%~10.3%。本方法可用于法庭与临床的毒物分析。     

短分离柱胶束液相色谱法同时测定酱油和食醋中的苯甲酸和山梨酸

建立了胶束液相色谱同时测定酱油和食醋中苯甲酸和山梨酸的检测方法。样品经过简单的稀释和过滤后直接注入高效液相色谱仪进行分析。分析柱使用两根串联的色谱保护柱(Zorbax Extend-C₁₈ 柱, 12.5 mm×4.6 mm, 5 μm),胶束流动相为含有2%(体积分数)异丙醇的0.01 mol/L十二烷基硫酸钠-0.01 mol/L醋酸钠(pH 4.9),检测器为二极管阵列检测器,检测波长为235 nm。苯甲酸和山梨酸在3.5 min内完全分离。检测的线性范围为10~100 μ g/mL,相关系数(r)为0.9999。检出限(S/N=3)和定量限(S/N=10)分别为0.04和0.14 μ g/mL。批间和批内精密度均不高于5.2%,高、中、低3个水平的加标回收率为90.5%~103.8%。该方法简单、快速,适用于食品质量监测的日常检测。     

高效液相色谱法直接测定血浆中的丝裂霉素C

本实验采用两根反相柱串联而形成的高效液相色谱柱切换装置，直接进样测定血浆中抗癌药物丝裂霉素Ｃ。第一根柱利用胶束流动相进行样品的纯化和富集，第二根柱对药物进行分析。紫外检测波长为３６５ｎｍ。药物的回收率在９５．９％～１００．３％之间，相对标准偏差为２．７６％。用该法对人和狗的局部和全身注射药物的血浆样品进行了测定。     

艾司唑仑荷移反应及分析应用

采用紫外分光光度法研究了π电子受体四氯对苯醌 (TCBQ)与电子给予体艾司唑仑的荷移反应 ,结果表明 ,TCBQ与艾司唑仑在pH 8.2的BR缓冲溶液中能形成稳定的荷移反应络合物 ,吸光度显著增强。据此建立了测定艾司唑仑的简单、快速、准确和灵敏的方法。艾司唑仑浓度在 0 .2～ 3 .2mg/L范围内符合比尔定律。r=0 .9992。荷移络合物在 3 1 6nm处的表观摩尔吸光系数为 8.5× 1 0 4L·mol-1·cm-1。方法用于片剂中艾司唑仑含量的测定 ,其回收率为 99.2 %～ 99.7% ;相对标准偏差为 0 .7%～2 .1 %。     

高效液相色谱法测定血浆中茶碱浓度

茶碱是治疗急、慢性阻塞性肺疾病及支气管哮喘的常用药物。为了配合临床用药量的调整和给药方案的建立,使药物浓度稳定地维持在最佳治疗范围内,避免毒副反应的发生,我们建立了一种操作简便、专一性强、取血量少的高效液相色谱法。     

胶束液相色谱法直接注射同时测定人血清中利凡诺和米非司酮

建立了一个简单、快速的胶束液相色谱方法,直接注射样品,同时测定人血清中利凡诺和米非司酮。分离于30℃反相C18柱上进行,流动相:含75 mmol/L的十二烷基硫酸钠和体积分数9%正丁醇的混合溶液(pH4.0),流速为1.2 mL/min。以苯为内标物。采用多波长模式检测,利凡诺、米非司酮、苯的检测波长分别为272、305、256 nm。直接注射的人血清样品体积为100μL。结果表明,利凡诺、米非司酮的校准曲线分别在20~1000、50~1000 ng/mL浓度范围内呈线性,检测限分别为4.9和13.8 ng/mL,精密度和准确度良好。该方法可直接注射样品同时测定人血清中两种药物,应用于评估同时使用两种药物的妇女的血药水平。     

硝西泮、氯硝西泮甲基衍生物的气相色谱-质谱分析

对硝西泮和氯硝西泮的衍生化条件、色谱及质谱行为进行了研究,确立了猪肉中硝西泮、氯硝西泮残留的GC-MS检测方法.应用5因素4水平的正交试验,最终确定衍生化条件为反应温度60℃、反应时间30 min、丙酮用量0.5 mL、衍生化试剂20μL、催化剂无水碳酸钾20mg,在此条件下可生成较完全的甲基衍生物.衍生物具有较好的气相色谱和电子轰击质谱行为.硝西泮衍生物的分子离子峰为m/z 295,基峰离子为m/z 267,主要碎片离子分别为m/z 206、220、248、294;氯硝西泮衍生物的分子离子峰为m/z 329,基峰离子为m/z 328,主要碎片离子分别为m/z205、220、248、266、294、331,并对这些离子的产生进行了解析.这些离子均具有较强的相对丰度,可作为其微量检测的多离子选择定性和确证,而基峰离子可用于单离子选择定量.用乙腈提取药物,C18固相萃取柱净化,GC-MS分析.本方法采用外标法定量,两种药物的标准曲线线性回归系数均在0.99以上,线性范围20～500 μg/L,回收率80%左右,相对标准偏差6.9%～14.9%,检出限16.7 μg/kg.     

金纳米粒子富集-高效液相色谱同时测定人血浆中三种氨基硫醇

建立了金纳米粒子富集-高效液相色谱-紫外检测(HPLC-UVD)同时测定人血浆中3种氨基硫醇(半胱氨酸(Cys)、高半胱氨酸(Hcys)、谷胱甘肽(GSH))的新方法。以Tween 20修饰的金纳米粒子作为选择探针萃取富集氨基硫醇。经二硫苏糖醇脱附后,采用SpursilTM C18柱(250 mm×4.6 mm, 5 μm)分离氨基硫醇,以60 mmol/L磷酸盐缓冲溶液(pH 2.0)等度洗脱,检测波长为200 nm。3种氨基硫醇的浓度分别在0.025～350 μmol/L、0.02～60 μmol/L、0.01～50 μmol/L内与峰面积具有良好的线性关系,相关系数均高于0.99。方法检出限(信噪比为3)分别为5.0、6.0和2.5 nmol/L,回收率为92.8%～106.0%。该方法能显著降低血浆样品中内源性物质的干扰,提高HPLC-UVD的选择性和灵敏度。将该方法应用于心血管病人血浆中上述氨基硫醇的分离测定,结果显示: 与对照组相比,疾病组血浆中的Hcys和GSH水平存在显著性差异,Cys不存在显著性差异。     

High performance liquid chromatography method for the determination of meropenem in human plasma

Summary This paper describes an HPLC method for the determination of meropenem in human plasma. The method uses solid phase extraction (SPE) of the samples and has good sensitivity, precision and accuracy. The limit of quantification in plasma samples is 0.02 μg mL⁻¹. Calibration curves were linear over a large dynamic range, namely within 0.02–50 μg mL⁻¹. The method was applied to the determination of meropenem levels in patients receiving meropenem, as a single dose or at steady state.     

Simultaneous determination of rifampicin and sulbactam in mouse plasma by high-performance liquid chromatography

A simple and rapid high-performance liquid chromatographic (HPLC) method with ultraviolet detection has been developed and validated for the simultaneous determination of rifampicin and sulbactam in mouse plasma. Plasma samples were deproteinized with acetonitrile and separated by HPLC on a RP-18 (125 x 4 mm, 5 microm) column and gradient elution with potassium dihydrogen phosphate solution (pH 4.5; 50 mm) and acetonitrile at a flow-rate of 1.0 mL/min. Rifampicin and sulbactam were monitored at 230 nm and confirmed by means of their UV spectra using a diode-array detector. The method was linear at plasma levels from 1 to 100 microg/mL for rifampicin and from 5 to 200 microg/mL for sulbactam. The limits of quantification were 0.6 microg/mL for rifampicin and 4.2 microg/mL for sulbactam. The intra- and inter-day precisions of the method (RSD) were lower than 5% for both compounds. Average recoveries of rifampicin and sulbactam from mice plasma were 98.2 and 89.3%, respectively. The developed method was successfully applied to the determination of the pharmacokinetic profile of both compounds in mice.     

微乳液相色谱法测定人血浆中丙泊酚浓度

建立了基于微乳液相色谱(MELC)的人血浆中丙泊酚浓度的测定方法。采用Hypersil BDS C18色谱柱分离,并考察了微乳流动相中各组分对溶质洗脱的影响。优化的色谱条件: 以0.5%醋酸（含有3.0%十二烷基硫酸钠（SDS）,0.8%正庚烷,6.0%正丁醇）微乳为流动相,流速为1.0 mL/min,荧光检测器激发波长(λex)为274 nm、发射波长(λem)为312 nm,柱温为室温。人血浆样品用流动相稀释并离心后,直接进样分析。丙泊酚在0.25～10 μg/mL质量浓度范围内呈良好的线性关系,方法的回收率为(98.2±1.9)%～(104.6±2.2)%;日内测定峰面积的相对标准偏差(RSD)为1.42%～2.43%,日间测定峰面积的RSD为2.75%～4.79%。该方法简便可行、重复性好,可用于人血浆中丙泊酚浓度的测定。     

Simultaneous determination of creatinine and uric acid in human plasma and urine by micellar electrokinetic chromatography

High performance capillary electrophoresis using a buffer solution containing micelles of ionic surfactant (e.g. sodium dodecyl sulfate), called micellar electrokinetic chromatography, has been applied to the separation and simultaneous determination of creatinine and uric acid in human plasma and urine. The sample was introduced into the capillary by siphoning an appropriate volume of untreated plasma or urine spiked with an internal standard (antipyrine). Creatinine, uric acid, and antipyrine were separated mutually, and from other endogeneous components within 18 min. The calibration plots showed good linearity (correlation coefficient > 0.999) over the concentration range needed for clinical analysis. Standard addition tests indicated that the recoveries of creatinine and uric acid from urine samples ranged, respectively, from 97 % to 106 % and 97.4 % to 108 % with a coefficient of variation (C.V.) of 3.3 % (n = 5), and that those from plasma samples ranged, respectively, from 100 % to 112 % and 101 % to 107 % with a C.V. of 4.7 % (n = 5). The results were in agreement with those obtained by conventional methods.     

Quantitative determination of domperidone in human plasma by ultraperformance liquid chromatography with electrospray ionization tandem mass spectrometry

A simple and sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for determining domperidone in human plasma. The analyte and internal standard (IS; mosapride) were isolated from plasma samples by protein precipitation with methanol (containing 0.1% formic acid). The chromatographic separation was performed on an Xterra MS C(18) Column (2.1 x 150 mm, 5.0 microm) with a gradient programme mobile phase consisting of 0.1% formic acid and acetonitrile at a flow rate of 0.30 mL/min. The total run time was 4.0 min. The analyses were carried out by multiple reaction monitoring using the parent-to-daughter combinations m/z 426 --> 175 and m/z 422 --> 198 (IS). The areas of peaks from the analyte and IS were used for quantification of domperidone. The method was validated according to the FDA guidelines on bioanalytical method validation. Validation results indicated that the lower limit of quantification was 0.2 ng/mL, and the assay exhibited a linear range of 0.2-60.0 ng/mL and gave a correlation coefficient (r(2)) of 0.999 or better. Quality control samples (0.4, 0.8, 15 and 50 ng/mL) in six replicates from three different analytical runs demonstrated an intra-assay precision (RSD) 4.43-6.26%, an inter-assay precision 5.25-7.45% and an overall accuracy (relative error) of <6.92%. The method can be applied to pharmacokinetic and bioequivalence studies of domperidone.     

Simultaneous determination of rosiglitazone and metformin in plasma by gradient liquid chromatography with UV detection

A novel, fast and simple liquid chromatographic method was developed and validated for the simultaneous determination of rosiglitazone and metformin in human plasma. The analysis was performed on a phenyl column (250 mm × 4.6 mm i.d., 5 μm) using a gradient method starting with mobile phase composed of acetonitrile:5 mM acetate buffer pH 5.5 (75:25, v/v). The flow rate was 1 mL min⁻¹. UV detection was performed at 245 nm and verapamil was used as internal standard. The total run time was less than 10 min. Sample preparation included a simple protein precipitation step with acetonitrile. Validation experiments were performed to demonstrate stability, specificity, sensitivity, linearity, accuracy, precision and robustness. The limit of quantification was 100 ng mL⁻¹ for rosiglitazone and 250 ng mL⁻¹ for metformin. The extraction recoveries were 100.02-105.0% for rosiglitazone and 105.64-103.88% for metformin. The method was applied with success to plasma samples obtained from diabetic patients undergoing treatment with rosiglitazone and metformin.     

Determination of phenazopyridine in human plasma by high performance liquid chromatography

Summary A simple, low-cost, sensitive and selective HPLC method was developed for the determination of phenazopyridine in human plasma. The method employs UV detection of phenazopyridine and of the internal Standard at 2 different wavelengths. Calibration curves were linear over a large dynamic range, i.e., within 0.05–10.0 μg mL⁻¹ with limit of quantification of 0.05 μg mL⁻¹, and a limit of detection of 0.01 μg mL⁻¹.